Keywords: merck, co, file, zocor, 80mg, usa, marketing
Merck & Co To File Zocor 80mg In USA
Article | 26 May 1997
- Merck & Co is to file for marketing clearance of a medium-doseformulation of its cholesterol-lowering drug, Zocor 80mg (simvastatin), with the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
